W. Peng

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy

Zhimin Ye, Liu Jiping, Fangzheng Wang, 2019, Medicine.

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.

W. Lei, Zhimin Ye, Yuezhen Wang, 2017, Oncotarget.

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma

Zhimin Ye, Liu Jiping, Fangzheng Wang, 2017, OncoTarget.

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma

W. Lei, Zhimin Ye, Fangzheng Wang, 2017, Oncotarget.

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients

Zhimin Ye, Liu Jiping, Fangzheng Wang, 2018, Journal of Cancer.

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

Zhimin Ye, Yuezhen Wang, Fangzheng Wang, 2017, Oncotarget.

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma

W. Lei, J. Haitao, Rihito Aizawa, 2017, OncoTarget.